Copyright
©The Author(s) 2023.
World J Clin Cases. Sep 16, 2023; 11(26): 6280-6288
Published online Sep 16, 2023. doi: 10.12998/wjcc.v11.i26.6280
Published online Sep 16, 2023. doi: 10.12998/wjcc.v11.i26.6280
Parameter (unit) | Measured value | Normal value |
White blood cells (103/µL) | 1.5 | 3.9–9.7 |
Neu (%) | 56 | 37–72 |
Lym (%) | 32 | 25–48 |
Mon (%) | 12 | 2–12 |
Eos (%) | 0 | 1–9 |
Bas (%) | 0 | 0–2 |
Hemoglobin (g/dL) | 15.4 | 13.4-17.1 |
Platelets (103/µL) | 103 | 153–346 |
Aspartate transaminase (IU/L) | 209 | 5–37 |
Alanine aminotransferase (IU/L) | 21 | 6–43 |
Lactic acid dehydrogenase (U/L) | 614 | 124–222 |
Alkaline phosphatase (U/L) | 69 | 38–113 |
Gamma-glutamyl transpeptidase (IU/L) | 54 | 0–75 |
Total bilirubin (mg/dL) | 0.5 | 0.4–1.2 |
Total protein (g/dL) | 6.5 | 6.5–8.5 |
Albumin (g/dL) | 3.3 | 3.8–5.2 |
Creatine kinase (U/L) | 2906 | 57–240 |
Blood urea nitrogen (mg/dL) | 63 | 9–21 |
Creatinine (mg/dL) | 4.2 | 0.6–1 |
Amylase (IU/L) | 198 | 43–124 |
Uric acid (mg/dL) | 7.7 | 3.5-6.9 |
Sodium (mEq/L) | 130 | 135–145 |
Potassium (mEq/L) | 5 | 3.5–5 |
Chloride (mEq/L) | 89 | 96–107 |
C-reactive protein (mg/dL) | 39.3 | 0–0.29 |
Procalcitonin (ng/mL) | 160.4 | 0-0.5 |
Plasma glucose (mg/dL) | 48 | 65–109 |
Glycated hemoglobin (NGSP) (%) | 5.1 | 4.6–6.2 |
Activated partial thromboplastin time (seconds) | 42.6 | 23–36 |
Prothrombin time (International normalized ratio) | 1.12 | 0.85–1.15 |
Fibrinogen and fibrin degradation products (μg/mL) | 14.7 | 0–10 |
D-dimer (μg/mL) | 3.3 | 0–1 |
Parameter (unit) | Measured value |
pH | 7.216 |
Partial pressure of arterial carbon dioxide (mmHg) | 31.3 |
partial pressure of arterial oxygen (mmHg) | 51.7 |
Bicarbonate ion (mmol/L) | 12.7 |
Base excess (mmol/L) | -13.9 |
Arterial oxygen saturation (%) | 76.7 |
Anion gap (mmol/L) | 20 |
Lactate (mmol/L) | 8.2 |
Fraction of inspiratory oxygen (%) | > 90 |
- Citation: Usuda D, Kato M, Sugawara Y, Shimizu R, Inami T, Tsuge S, Sakurai R, Kawai K, Matsubara S, Tanaka R, Suzuki M, Shimozawa S, Hotchi Y, Osugi I, Katou R, Ito S, Mishima K, Kondo A, Mizuno K, Takami H, Komatsu T, Oba J, Nomura T, Sugita M. Secondary pulmonary infection by Fusarium solani and Aspergillus niger during systemic steroid treatment for COVID-19: A case report. World J Clin Cases 2023; 11(26): 6280-6288
- URL: https://www.wjgnet.com/2307-8960/full/v11/i26/6280.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i26.6280